Literature DB >> 17171444

Successful treatment of refractory duodenal Crohn's disease with infliximab.

Masaru Odashima1, Michiro Otaka, Mario Jin, Youhei Horikawa, Tamostu Matsuhashi, Reina Ohba, Shigeto Koizumi, Nobukatsu Kinoshita, Taiji Takahashi, Sumio Watanabe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17171444     DOI： 10.1007/s10620-006-9585-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.487


× No keyword cloud information.
  4 in total

1.  Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.

Authors:  G D'haens; S Van Deventer; R Van Hogezand; D Chalmers; C Kothe; F Baert; T Braakman; T Schaible; K Geboes; P Rutgeerts
Journal:  Gastroenterology       Date:  1999-05       Impact factor: 22.682

2.  Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients.

Authors:  A Di Sabatino; R Ciccocioppo; L Benazzato; G C Sturniolo; G R Corazza
Journal:  Aliment Pharmacol Ther       Date:  2004-05-01       Impact factor: 8.171

3.  A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

Authors:  S R Targan; S B Hanauer; S J van Deventer; L Mayer; D H Present; T Braakman; K L DeWoody; T F Schaible; P J Rutgeerts
Journal:  N Engl J Med       Date:  1997-10-09       Impact factor: 91.245

4.  Duodenal Crohn's disease: an analysis of 89 cases.

Authors:  F W Nugent; M A Roy
Journal:  Am J Gastroenterol       Date:  1989-03       Impact factor: 10.864
  4 in total
  5 in total

Review 1.  The endoscopic findings of the upper gastrointestinal tract in patients with Crohn's disease.

Authors:  Yoshiki Nomura; Kentaro Moriichi; Mikihiro Fujiya; Toshikatsu Okumura
Journal:  Clin J Gastroenterol       Date:  2017-07-10

2.  Pyloric stenosis associated Crohn's disease responding to adalimumab therapy.

Authors:  Sameer Gaggar; John Scott; Nicholas Thompson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-12-06

3.  Refractory duodenal Crohn's disease successfully treated with infliximab.

Authors:  You Lim Kim; Young Sook Park; Eun Kyoung Park; Dae Rim Park; Gyu Sik Choi; Sang Bong Ahn; Seong Hwan Kim; Yun Ju Jo
Journal:  Intest Res       Date:  2014-01-28

4.  Upper gastrointestinal tract involvement in Crohn's disease: A case report.

Authors:  Michael Orrell; Cas van 't Hullenaar; Jonathan Gosling
Journal:  Int J Surg Case Rep       Date:  2021-03-23

5.  Qing Hua Chang Yin attenuates lipopolysaccharide-induced inflammatory response in human intestinal cells by inhibiting NF-κB activation.

Authors:  Xiao Ke; Jingtuan Chen; Xin Zhang; Wenyi Fang; Chunbo Yang; Jun Peng; Youqin Chen; Thomas J Sferra
Journal:  Exp Ther Med       Date:  2013-04-22       Impact factor: 2.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.